Th1/Th2相关细胞因子在不同程度宫颈病变中变化的研究进展
Research Progress on Changes of Th1/Th2 Related Cytokines in Different Degrees of Cervical Lesions
摘要: 子宫颈癌目前为我国女性恶性生殖道肿瘤首位，其主要因素为高危型HPV的持续感染。而机体局部的免疫功能对病毒的清除以及疾病的进展有着重要作用。近年来关于恶性肿瘤与Th1/Th2型细胞因子平衡失调关系的研究已成为热点，而目前对于Th1/Th2相关细胞因子在不同程度的宫颈病变中相关研究却并不多见，因此，本文就Th1/Th2相关细胞因子在不同程度的宫颈病变中的变化进行简要概述。
Abstract: Currently, cervical cancer is the first malignancy of the genital tract in women in my country, and its main factor is the persistent infection of high-risk HPV. The body’s local immune function plays an important role in virus clearance and disease progression. In recent years, research on the rela-tionship between malignant tumors and Th1/Th2 cytokine balance has become a hot spot, but there are few related studies on Th1/Th2 related cytokines in cervical lesions of different degrees. Therefore, this article provides a brief overview of the changes in Th1/Th2-related cytokines in dif-ferent degrees of cervical lesions.
文章引用：刘艳君, 杜蓉. Th1/Th2相关细胞因子在不同程度宫颈病变中变化的研究进展[J]. 临床医学进展, 2023, 13(2): 2046-2051. https://doi.org/10.12677/ACM.2023.132285

参考文献

[1] (2020) Erratum: Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 70, 313. [Google Scholar] [CrossRef] [PubMed]
[2] Lin, W., Niu, Z.Y., Zhang, H.L., et al. (2019) Imbalance of Th1/Th2 and Th17/Treg during the Development of Uterine Cervical Cancer. International Journal of Clinical and Experimental Pa-thology, 12, 3604-3612.
https://pubmed.ncbi.nlm.nih.gov/31934210/
[3] Small, W., Bacon, M.A., Bajaj, A., et al. (2017) Cervical Cancer: A Global Health Crisis. Cancer, 123, 2404-2412. https://pubmed.ncbi.nlm.nih.gov/28464289/ [Google Scholar] [CrossRef] [PubMed]
[4] 林农. 女性阴道微生态环境与生殖道感染[J]. 国际生殖健康/计划生育杂志, 2010, 29(5): 377-380.
[5] 张建平, 刘梅兰. 生殖道微生态环境[J]. 实用妇产科志, 2008(6): 321-322.
[6] 任莉, 田晓予. Th1/Th2漂移与宫颈HPV感染及宫颈癌关系的研究进展[J]. 医学综述, 2006(17): 1042-1044.
[7] 陈远崇, 陈竹雨. 结直肠癌患者血清Th1/Th2细胞因子水平变化及其临床意义研究[J]. 中国全科医学, 2011, 14(36): 4136-4138.
[8] Hadi, A.A. and Vladimirovna, M.E. (2021) Association between Promoter Polymorphisms of IL-1B, IL-4 and IL-6 Genes and a Viral Load Infected Women with Human Papillomavirus. Journal of Reproduction & Infertility, 22, 92-102.
https://pubmed.ncbi.nlm.nih.gov/34041005/
[9] Chiranjib, C., Ranjan, S.A., Garima, S., et al. (2020) The Inter-play among miRNAs, Major Cytokines, and Cancer-Related Inflammation. Molecular Therapy—Nucleic Acids, 20, 606-620. https://pubmed.ncbi.nlm.nih.gov/32348938/ [Google Scholar] [CrossRef] [PubMed]
[10] 曾君, 翟志芳. IL-2在系统性红斑狼疮中的作用研究进展[J]. 中国免疫学杂志, 2022, 38(8): 1012-1016.
[11] 杨华, 赵璐, 陈叙. Th1/Th2平衡调控对妇产科疾病影响的研究进展[J]. 国际妇产科学杂志, 2018, 45(5): 101-103+122.
[12] Saravia, J., Chapman, N.M. and Chi, H. (2019) Helper T Cell Differentiation. Cellular & Molecular Immunology, 16, 634-643. https://pubmed.ncbi.nlm.nih.gov/30867582/ [Google Scholar] [CrossRef] [PubMed]
[13] 刘薇. Th1/Th2细胞与妇科肿瘤[J]. 国外医学. 妇产科学分册, 2002, 29(4): 18-20.
[14] Masahiko, S., Takeshi, N., Hisao, K., et al. (2002) Decreased Production of Interleukin-12 and Type 2 Immune Responses Are Marked Incachectic Patients with Colorectal and Gastric Cancer. Journal of Clinical Gastroenterology, 34, 416-420. https://pubmed.ncbi.nlm.nih.gov/11907352/ [Google Scholar] [CrossRef] [PubMed]
[15] Park, A.Y. and Scott, P. (2001) Il-12: Keeping Cell-Mediated Immunity Alive. Scandinavian Journal of Immunology, 53, 529-532. https://pubmed.ncbi.nlm.nih.gov/11422900/ [Google Scholar] [CrossRef] [PubMed]
[16] Feng, C.Y., Dong, J.X., Chang, W.Q., et al. (2018) The Progress of Methylation Regulation in Gene Expression of Cervical Cancer. International Journal of Genomics, 2018, Article ID: 8260652. https://pubmed.ncbi.nlm.nih.gov/29850477/ [Google Scholar] [CrossRef] [PubMed]
[17] 张敏, 肖凤仪, 李波, 熊瑛, 叶冬梅. 高危型HPV感染与宫颈病变组织IFN-γ、IL-10表达的相关性研究[J]. 海南医学院学报, 2015, 21(6): 58-60+63.
[18] 蒋艳萍, 曹来英, 洛若愚. CIN宫颈组织中Treg细胞和Th1/Th2细胞因子的表达及意义[J]. 实用癌症杂志, 2010, 25(6): 14-17.
[19] Usyk, M., Zolnik, C.P., Castle, P.E., et al. (2020) Cervicovaginal Microbiome and Natural History of HPV in a Longitudinal Study. PLOS Pathogens, 16, e1008376. https://pubmed.ncbi.nlm.nih.gov/32214382/ [Google Scholar] [CrossRef] [PubMed]
[20] Berti, F.C.B., et al. (2017) The Role of Interleukin 10 in Human Papilloma Virus Infection and Progression to Cervical Carcinoma. Cytokine and Growth Factor Reviews, 34, 1-13. https://pubmed.ncbi.nlm.nih.gov/28365229/ [Google Scholar] [CrossRef] [PubMed]
[21] 张建民, 杨幼萍, 朱扬丽. 子宫颈鳞状细胞癌的癌前病变诊断和鉴别诊断[J]. 临床与实验病理学杂志, 2011, 27(5): 455-462.
[22] Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://pubmed.ncbi.nlm.nih.gov/30207593/ [Google Scholar] [CrossRef] [PubMed]
[23] 宋元梓, 张春华, 康凌, 宋晓玲, 李小华. 女性尖锐湿疣HPV感染亚型分布及Th1/Th2细胞免疫失衡研究[J]. 中华医院感染学杂志, 2020, 30(21): 3341-3345.
[24] 贺雯, 任琛琛, 杨立, 刘灵, 李飞燕, 许晴晴, 陈飞, 潘学景. 阴道灌洗液中TNF-α、IL-12、IL-10表达与高危型HPV持续感染的相关性[J]. 现代妇产科进展, 2019, 28(2): 86-89.
[25] 杨东晓, 李红娟, 田晓娜, 牛庆玲, 李红雨. 高危型HPV感染对宫颈病变组织Th1/Th2相关指标表达的影响研究[J]. 中华医院感染学杂志, 2017, 27(3): 187-189.
[26] 刘易斯, 王敏, 陶陶. 宫颈组织中白介素-2、白介素-4在HPV感染不同类型宫颈病变中的表达[J]. 中国继续医学教育, 2017, 9(27): 56-58.
[27] 潘倩雄, 叶晓智, 杨丽红, 冯维良, 丁蓉. 慢性宫颈炎并发HPV感染者Th1/Th2细胞因子变化及微波疗效分析[J]. 中华医院感染学杂志, 2020, 30(19): 3016-3020.
[28] 林静, 韩永智, 李楠, 李小红, 董秀芹. 人乳头状瘤病毒感染和复发性尖锐湿疣与细胞免疫水平的关系研究[J]. 中华医院感染学杂志, 2017, 27(11): 2502-2505.
[29] 中国抗癌协会妇科肿瘤专业委员会. 子宫颈癌诊断与治疗指南(2021年版) [J]. 中国癌症杂志, 2021, 31(6): 474-489.
[30] 赛星月, 李晓红, 杜蓉. 宫颈病变患者外周血中TH1/TH2漂移状态与T-bet/GATA-3的表达及意义[J]. 中国医药导报, 2020, 17(11): 76-79.
[31] 董勇佔, 王香. 宫颈癌及宫颈上皮瘤变患者Th1/Th2水平变化及其相关炎性因子的检测与临床意义[J]. 中国临床新医学, 2015, 8(10): 943-946.
[32] 邹晶晶, 朱小飞, 余杨. 高危型人乳头状瘤病毒载量和Th1/Th2不均衡表达对宫颈病变进程的影响[J]. 新乡医学院学报, 2019, 36(11): 1055-1059.
[33] 付艳丽, 余杨, 卫玮, 邹晶晶, 孙翔. 高危型人乳头状瘤病毒载量和Th1/Th2不均衡表达预测宫颈癌变进程的研究[J]. 实用肿瘤学杂志, 2018, 32(6): 533-537.
[34] Tang, H.D., Qiao, J. and Fu, Y.-X. (2016) Immunotherapy and Tumor Microenvironment. Cancer Letters, 370, 85-90. https://pubmed.ncbi.nlm.nih.gov/26477683/ [Google Scholar] [CrossRef] [PubMed]
[35] 张玲, 宋华林, 曲芃芃. 高危型人乳头瘤病毒持续感染宫颈局部免疫状态的研究[J]. 天津医药, 2016, 44(11): 1363-1366.
[36] 季菲, 何艳, 杨丽, 丁岩, 杜蓉. 宫颈癌患者Th1/Th2细胞因子的表达及其预后意义[J]. 重庆医学, 2018, 47(33): 4229-4233.
[37] 熊文栋, 叶宣梅, 王连云, 耿筱虹. T淋巴细胞亚群及其细胞因子在宫颈癌患者外周血中的变化及意义[J]. 中国卫生检验杂志, 2020, 30(6): 695-697+709.
[38] Lin, W., Zhang, H.L., Niu, Z.Y., et al. (2020) The Disease Stage-Associated Imbalance of Th1/Th2 and Th17/Treg in Uterine Cervical Cancer Patients and Their Recovery with the Reduction of Tumor Burden. BMC Women’s Health, 20, 126. https://pubmed.ncbi.nlm.nih.gov/32552719/ [Google Scholar] [CrossRef] [PubMed]
[39] 李志杰, 啜俊波, 林楠, 等. 宫颈癌组织中Th1/Th2类细胞因子的漂移研究[J]. 现代生物医学进展, 2014, 14(7): 1357-1360.
[40] 姜爱华, 孙俊红, 张芳芳, 李自平. 宫颈癌患者HPV感染状况及外周血Th1/Th2细胞因子变化研究[J]. 实用癌症杂志, 2021, 36(4): 555-558.
[41] 陈仲波, 余红萍, 朱笕青, 周建松, 郑智国. 合并HPV感染宫颈癌患者外周血Th1/Th2细胞免疫功能变化及临床意义[J]. 中华医院感染学杂志, 2016, 26(24): 5677-5679.
[42] Kusuda, T., Shigemasa, K., Arihiro, K., et al. (2005) Relative Expression Levels of Th1 and Th2 Cytokine mRNA Are Independent Prognostic Factors in Patients with Ovarian Cancer. Oncology Reports, 13, 1153-1158. https://pubmed.ncbi.nlm.nih.gov/15870936/ [Google Scholar] [CrossRef] 
[43] Castle, P.E., Hildesheim, A., Bowman, F.P., et al. (2002) Cervical Con-centrations of Interleukin-10 and Interleukin-12 Do Not Correlate with Plasma Levels. Journal of Clinical Immunology, 22, 23-27. https://pubmed.ncbi.nlm.nih.gov/11958590/ [Google Scholar] [CrossRef] 

为你推荐